|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 31/18 | (2006.01) |
| C07D 471/04 | (2006.01) | ||
| A61K 31/519 | (2006.01) |
| (11) | Number of the document | 3986561 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20743783.1 |
| Date of filing the European patent application | 2020-06-17 | |
| (97) | Date of publication of the European application | 2022-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-14 |
| (46) | Date of publication of the claims translation | 2024-04-25 |
| (86) | Number | PCT/IB2020/055653 |
| Date | 2020-06-17 |
| (87) | Number | WO 2020/254985 |
| Date | 2020-12-24 |
| (30) | Number | Date | Country code |
| 201962863406 P | 2019-06-19 | US |
| (72) |
GILLIS, Eric P , US
IWUAGWU, Christiana , US
|
| (73) |
VIIV Healthcare UK (No.5) Limited ,
GSK Medicines Research Centre
Gunnels Wood Road, Stevenage SG1 2NY,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirido[2,3-d]pirimidino dariniai kaip žmogaus imunodeficito viruso replikacijos inhibitoriai |
| PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 6 | 139.00 EUR |
| 2026-06-17 |